ACOG Committee Opinion No. 375: Brand versus generic oral contraceptives.
The U.S. Food and Drug Administration considers generic and brand name oral contraceptive (OC) products clinically equivalent and interchangeable. The American College of Obstetricians and Gynecologists supports patient or clinician requests for branded OCs or continuation of the same generic or branded OCs if the request is based on clinical experience or concerns regarding packaging or compliance, or if the branded product is considered a better choice for that individual patient.
American College of Obstetricians and Gynecologists, 409 12th Street, Washington, DC 20090, USA.
D003278:Contraceptives, Oral, Hormonal / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016568:Drugs, Generic / Q000493:pharmacokinetics* / Q000627:therapeutic use; D005260:Female; D006176:Gynecology; D006801:Humans; D010349:Patient Compliance; D017060:Patient Satisfaction; D010818:Practice Patterns, Physicians' / Q000191:economics; D013810:Therapeutic Equivalency
D003278:Contraceptives, Oral, Hormonal; D016568:Drugs, Generic